Literature DB >> 27786572

Haplo-cord transplant: HLA-matching determines graft dominance.

Koen van Besien1, Nebu Koshy1, Usama Gergis1, Sebastian Mayer1, Melissa Cushing1, Hannah Rennert1, Ronit Reich-Slotky1, Tomer Mark1, Roger Pearse1, Adriana Rossi1, Adrienne Phillips1, Liljana Vasovic1, Rosanna Ferrante1, Yen-Michael Hsu1, Tsiporah Shore1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27786572      PMCID： PMC5832029          DOI： 10.1080/10428194.2016.1248964

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  14 in total

1.  Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.

Authors:  Koen van Besien; Parameswaran Hari; Mei-Jie Zhang; Hong-Tao Liu; Wendy Stock; Lucy Godley; Olatoyosi Odenike; Richard Larson; Michael Bishop; Amittha Wickrema; Usama Gergis; Sebastian Mayer; Tsiporah Shore; Stephanie Tsai; Joanna Rhodes; Melissa M Cushing; Sandra Korman; Andrew Artz
Journal:  Haematologica       Date:  2016-02-11       Impact factor: 9.941

Review 2.  Alternative donor transplantation--"mixing and matching": the role of combined cord blood and haplo-identical donor transplantation (haplo-cord SCT) as a treatment strategy for patients lacking standard donors?

Authors:  Hongtao Liu; Koen van Besien
Journal:  Curr Hematol Malig Rep       Date:  2015-03       Impact factor: 3.952

3.  Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.

Authors:  Stephanie B Tsai; Hongtao Liu; Tsiporah Shore; Yun Fan; Michael Bishop; Melissa M Cushing; Usama Gergis; Lucy Godley; Justin Kline; Richard A Larson; Guadalupe Martinez; Sebastian Mayer; Olatoyosi Odenike; Wendy Stock; Amittha Wickrema; Koen van Besien; Andrew S Artz
Journal:  Biol Blood Marrow Transplant       Date:  2016-02-19       Impact factor: 5.742

Review 4.  Topping it up: methods to improve cord blood transplantation outcomes by increasing the number of CD34+ cells.

Authors:  Caroline A Lindemans; Koen van Besien
Journal:  Cytotherapy       Date:  2015-03-17       Impact factor: 5.414

5.  Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation.

Authors:  S Giralt; P F Thall; I Khouri; X Wang; I Braunschweig; C Ippolitti; D Claxton; M Donato; J Bruton; A Cohen; M Davis; B S Andersson; P Anderlini; J Gajewski; S Kornblau; M Andreeff; D Przepiorka; N T Ueno; J Molldrem; R Champlin
Journal:  Blood       Date:  2001-02-01       Impact factor: 22.113

6.  Haplo-cord transplantation using CD34+ cells from a third-party donor to speed engraftment in high-risk patients with hematologic disorders.

Authors:  Mi Kwon; Guiomar Bautista; Pascual Balsalobre; Isabel Sánchez-Ortega; David Serrano; Javier Anguita; Ismael Buño; Rafael Fores; Carmen Regidor; José A García Marco; Carlos Vilches; Rosario de Pablo; Manuel N Fernández; Jorge Gayoso; Rafael Duarte; José Luis Díez-Martín; Rafael Cabrera
Journal:  Biol Blood Marrow Transplant       Date:  2014-09-22       Impact factor: 5.742

Review 7.  The role of HLA antibodies in allogeneic SCT: is the 'type-and-screen' strategy necessary not only for blood type but also for HLA?

Authors:  S Yoshihara; K Taniguchi; H Ogawa; H Saji
Journal:  Bone Marrow Transplant       Date:  2012-01-09       Impact factor: 5.483

8.  Sufficient Immunosuppression with Thymoglobulin Is Essential for a Successful Haplo-Myeloid Bridge in Haploidentical-Cord Blood Transplantation.

Authors:  Caroline A Lindemans; Liane C J Te Boome; Rick Admiraal; Els C Jol-van der Zijde; Anne M Wensing; A Birgitta Versluijs; Marc B Bierings; Jürgen Kuball; Jaap J Boelens
Journal:  Biol Blood Marrow Transplant       Date:  2015-06-26       Impact factor: 5.742

9.  Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions.

Authors:  Hongtao Liu; Elizabeth S Rich; Lucy Godley; Olatoyosi Odenike; Loren Joseph; Susana Marino; Justin Kline; Vu Nguyen; John Cunningham; Richard A Larson; Paula del Cerro; Linda Schroeder; Lisa Pape; Wendy Stock; Amittha Wickrema; Andrew S Artz; Koen van Besien
Journal:  Blood       Date:  2011-10-05       Impact factor: 22.113

10.  Cord blood chimerism and relapse after haplo-cord transplantation.

Authors:  Koen van Besien; Nebu Koshy; Usama Gergis; Sebastian Mayer; Melissa Cushing; Hannah Rennert; Ronit Reich-Slotky; Tomer Mark; Roger Pearse; Adriana Rossi; Adrienne Phillips; Liljana Vasovic; Rosanna Ferrante; Yen-Michael Hsu; Tsiporah Shore
Journal:  Leuk Lymphoma       Date:  2016-06-23
View more
  3 in total

1.  Cord blood transplants supported by unrelated donor CD34+ progenitor cells.

Authors:  Alexandra Gomez-Arteaga; Nina Orfali; Danielle Guarneri; Melissa M Cushing; Usama Gergis; Jingmei Hsu; Yen-Michael S Hsu; Sebastian A Mayer; Adrienne A Phillips; Stacy A Chase; Asmaa E Mokhtar; Tsiporah B Shore; Koen Van Besien
Journal:  Bone Marrow Transplant       Date:  2020-06-09       Impact factor: 5.483

2.  Engraftment kinetics after transplantation of double unit cord blood grafts combined with haplo-identical CD34+ cells without antithymocyte globulin.

Authors:  Ioannis Politikos; Sean M Devlin; Maria E Arcila; Jonathan C Barone; Molly A Maloy; Kristine A Naputo; Josel D Ruiz; Christopher M Mazis; Andromachi Scaradavou; Scott T Avecilla; Parastoo B Dahi; Sergio A Giralt; Katherine C Hsu; Ann A Jakubowski; Esperanza B Papadopoulos; Miguel A Perales; Craig S Sauter; Roni Tamari; Doris M Ponce; Richard J O'Reilly; Juliet N Barker
Journal:  Leukemia       Date:  2020-06-18       Impact factor: 11.528

3.  A Prospective Trial Comparing Haploidentical Donor Transplantation With Cord Blood Versus HLA-Matched Sibling Donor Transplantation for Hematologic Malignancy Patients.

Authors:  Wenyi Lu; Xin Jin; Hairong Lyu; Xue Bai; Haibo Zhu; Xin Li; Xia Xiao; Juanxia Meng; Ting Yuan; Qing Li; Juan Mu; Cuicui Lyu; Yili Jiang; Yunxiong Wei; Xia Xiong; Meng Zhang; Mingfeng Zhao
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.064
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.